# NeuX Capital

> NeuX Capital is a VC fund backing Semiconductor and Machine Learning. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jul 2023
- Lead investor: 0%
- Last updated: Aug 2026

NeuX Capital is an investment firm.

## Contacts

5 contacts available for NeuX Capital. Shizune tracks 1 team members at NeuX Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/neux-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Semiconductor | 1 | 33% |
| Machine Learning | 1 | 33% |
| Health Diagnostics | 1 | 33% |
| Artificial Intelligence | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Series A | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 2 | 67% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Xu Jing | founding partner | 2 | https://shizune.co/investors/profile/xu-jing-0a55 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Atantares | We are a development stage startup enabling the next generation of precision medicine by fusing biochip and AI technologies. | $14.1M | Seed | Jul 31, 2023 |  |
| Degron Therapeutics | Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment. | $22M | Series A | Jun 09, 2022 |  |
| Metanovas Biotech | Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning. | $10M | Seed | Mar 30, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Med-Fine Capital](https://shizune.co/investors/profile/med-fine-capital) — VC Fund, 3 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 2 deals together
- [Sinopharm Capital](https://shizune.co/investors/profile/sinopharm-capital) — VC Fund, 2 deals together
- [Alibaba Health Information Technology](https://shizune.co/investors/profile/alibaba-health-information-technology) — VC Fund, 1 deal together
- [Asia Green Fund](https://shizune.co/investors/profile/asia-green-fund) — VC Fund, 1 deal together
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does NeuX Capital invest in?

NeuX Capital invests primarily in Semiconductor, Machine Learning and Health Diagnostics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact NeuX Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at NeuX Capital?

The team at NeuX Capital includes Xu Jing (founding partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co